Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Parent and child perspectives on family interactions related to melanoma risk and prevention after CDKN2A/p16 testing of minor children.

Wu YP, Aspinwall LG, Parsons B, Stump TK, Nottingham K, Kohlmann W, Champine M, Cassidy P, Leachman SA.

J Community Genet. 2020 Jan 18. doi: 10.1007/s12687-020-00453-9. [Epub ahead of print]

PMID:
31955387
2.

Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer.

Del Fiol G, Kohlmann W, Bradshaw RL, Weir CR, Flynn M, Hess R, Schiffman JD, Nanjo C, Kawamoto K.

JCO Clin Cancer Inform. 2020 Jan;4:1-9. doi: 10.1200/CCI.19.00120.

3.

Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.

Li C, Liu T, Tavtigian SV, Boucher K, Kohlmann W, Cannon-Albright L, Grossman D.

Melanoma Res. 2019 Sep 24. doi: 10.1097/CMR.0000000000000645. [Epub ahead of print]

PMID:
31567591
4.

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.

Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C.

Cancer Med. 2019 Nov;8(15):6789-6798. doi: 10.1002/cam4.2534. Epub 2019 Sep 18.

5.

A pilot study of a telehealth family-focused melanoma preventive intervention for children with a family history of melanoma.

Wu YP, Boucher K, Hu N, Hay J, Kohlmann W, Aspinwall LG, Bowen DJ, Parsons BG, Nagelhout ES, Grossman D, Mooney K, Leachman SA, Tercyak KP.

Psychooncology. 2020 Jan;29(1):148-155. doi: 10.1002/pon.5232. Epub 2019 Nov 10.

PMID:
31520429
6.

CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.

Stump TK, Aspinwall LG, Drummond DM, Taber JM, Kohlmann W, Champine M, Cassidy PB, Petrie T, Liley B, Leachman SA.

Genet Med. 2020 Jan;22(1):26-34. doi: 10.1038/s41436-019-0608-9. Epub 2019 Aug 2.

PMID:
31371819
7.

Determining Onset for Familial Breast and Colorectal Cancer from Family History Comments in the Electronic Health Record.

Mowery DL, Kawamoto K, Bradshaw R, Kohlmann W, Schiffman JD, Weir C, Borbolla D, Chapman WW, Del Fiol G.

AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:173-181. eCollection 2019.

8.

Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.

McCrary HC, Babajanian E, Calquin M, Carpenter P, Casazza G, Naumer A, Greenberg S, Kohlmann W, Cannon R, Monroe MM, Hunt JP, Buchmann L.

JAMA Otolaryngol Head Neck Surg. 2019 Jul 1;145(7):641-646. doi: 10.1001/jamaoto.2019.1110.

PMID:
31194233
9.

Difference of Opinion: Spousal Influence on Cancer Risk-reducing Behavior.

Birmingham WC, Reblin M, Kohlmann W, Graff TC.

Am J Health Behav. 2019 May 1;43(3):582-590. doi: 10.5993/AJHB.43.3.12.

PMID:
31046888
10.

Population-based relative risks for specific family history constellations of breast cancer.

Albright FS, Kohlmann W, Neumayer L, Buys SS, Matsen CB, Kaphingst KA, Cannon-Albright LA.

Cancer Causes Control. 2019 Jun;30(6):581-590. doi: 10.1007/s10552-019-01171-5. Epub 2019 Apr 27.

PMID:
31030355
11.

Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma.

Colonna S, Curtin K, Johnson E, Kohlmann W, Wright J, Kirchhoff A, Tavtigian S, Schiffman J.

Int J Cancer Clin Res. 2019;6(1). pii: 107. doi: 10.23937/2378-3419/1410107. Epub 2019 Feb 25.

12.

The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.

Hummel S, Kohlmann W, Kollmeyer TM, Jenkins R, Sonnen J, Palmer CA, Colman H, Abbott D, Cannon-Albright L, Cohen AL.

BMC Cancer. 2019 Mar 1;19(1):190. doi: 10.1186/s12885-019-5381-2.

13.

Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome.

Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman JD.

Pediatr Blood Cancer. 2019 May;66(5):e27629. doi: 10.1002/pbc.27629. Epub 2019 Feb 4.

PMID:
30719841
14.

Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis.

Petersen J, Koptiuch C, Wu YP, Mooney R, Elrick A, Szczotka K, Keener M, Pappas L, Kanth P, Soisson A, Kohlmann W, Kaphingst KA.

Patient Educ Couns. 2018 Nov;101(11):2011-2017. doi: 10.1016/j.pec.2018.07.021. Epub 2018 Jul 26.

15.

Pancreatic cancer as a sentinel for hereditary cancer predisposition.

Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV.

BMC Cancer. 2018 Jun 27;18(1):697. doi: 10.1186/s12885-018-4573-5.

16.

Lynch Syndrome.

Kohlmann W, Gruber SB.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2004 Feb 5 [updated 2018 Apr 12].

17.

Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children.

Wu YP, Parsons BG, Mooney R, Aspinwall LG, Cloyes K, Hay JL, Kohlmann W, Grossman D, Leachman SA.

J Community Health. 2018 Oct;43(5):993-1001. doi: 10.1007/s10900-018-0516-y.

18.

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Aspinwall LG, Stump TK, Taber JM, Drummond DM, Kohlmann W, Champine M, Leachman SA.

Transl Behav Med. 2018 Jan 29;8(1):29-43. doi: 10.1093/tbm/ibx011.

19.

Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.

Stump TK, Aspinwall LG, Kohlmann W, Champine M, Hauglid J, Wu YP, Scott E, Cassidy P, Leachman SA.

J Genet Couns. 2018 Aug;27(4):955-967. doi: 10.1007/s10897-017-0185-5. Epub 2018 Jan 19.

20.

Melanoma risk assessment based on relatives' age at diagnosis.

Wu YP, Kohlmann W, Curtin K, Yu Z, Hanson HA, Hashibe M, Parsons BG, Wong J, Schiffman JD, Grossman D, Leachman SA.

Cancer Causes Control. 2018 Feb;29(2):193-199. doi: 10.1007/s10552-017-0994-8. Epub 2017 Dec 14.

21.

Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study.

Martin C, Leiser CL, O'Neil B, Gupta S, Lowrance WT, Kohlmann W, Greenberg S, Pathak P, Smith KR, Hanson HA.

J Natl Cancer Inst. 2018 May 1;110(5):527-533. doi: 10.1093/jnci/djx237.

22.

Intramucosal lipomas of the colon implicate Cowden syndrome.

Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner MP.

Mod Pathol. 2018 Apr;31(4):643-651. doi: 10.1038/modpathol.2017.161. Epub 2017 Dec 1.

23.

A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma.

Wu YP, Nagelhout E, Aspinwall LG, Boucher KM, Parsons BG, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Leachman SA.

Patient Educ Couns. 2018 Mar;101(3):452-459. doi: 10.1016/j.pec.2017.10.008. Epub 2017 Oct 19.

24.

Support and negation of colorectal cancer risk prevention behaviors: analysis of spousal discussions.

Reblin M, Birmingham WC, Kohlmann W, Graff T.

Psychol Health Med. 2018 Jun;23(5):548-554. doi: 10.1080/13548506.2017.1381747. Epub 2017 Oct 6.

PMID:
28984149
25.

Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.

Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, Buys SS, Stroup AM, Campo RA, Flores KG, Vicuña B, Schwartz MD, Kinney AY.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1772-1780. doi: 10.1158/1055-9965.EPI-17-0389. Epub 2017 Sep 29.

26.

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O'Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, Stoffel EM, Koeppe E, Weitzel JN, Slavin TP, Nehoray B, Robson M, Walsh M, Manelli L, Villani A, Thomas DM, Savage SA.

JAMA Oncol. 2017 Dec 1;3(12):1634-1639. doi: 10.1001/jamaoncol.2017.1968. Erratum in: JAMA Oncol. 2018 Apr 1;4(4):590.

27.

Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Wasserman JD, Tomlinson GE, Druker H, Kamihara J, Kohlmann WK, Kratz CP, Nathanson KL, Pajtler KW, Parareda A, Rednam SP, States LJ, Villani A, Walsh MF, Zelley K, Schiffman JD.

Clin Cancer Res. 2017 Jul 1;23(13):e123-e132. doi: 10.1158/1078-0432.CCR-17-0548. Review.

28.

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood.

Achatz MI, Porter CC, Brugières L, Druker H, Frebourg T, Foulkes WD, Kratz CP, Kuiper RP, Hansford JR, Hernandez HS, Nathanson KL, Kohlmann WK, Doros L, Onel K, Schneider KW, Scollon SR, Tabori U, Tomlinson GE, Evans DGR, Plon SE.

Clin Cancer Res. 2017 Jul 1;23(13):e107-e114. doi: 10.1158/1078-0432.CCR-17-0790. Review.

29.

Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient.

Druker H, Zelley K, McGee RB, Scollon SR, Kohlmann WK, Schneider KA, Wolfe Schneider K.

Clin Cancer Res. 2017 Jul 1;23(13):e91-e97. doi: 10.1158/1078-0432.CCR-17-0834. Review.

30.

Colon Pathology Characteristics in Li-Fraumeni Syndrome.

Rengifo-Cam W, Shepherd HM, Jasperson KW, Samadder NJ, Samowitz W, Tripp SR, Schiffman JD, Kohlmann W.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):140-141. doi: 10.1016/j.cgh.2017.06.017. Epub 2017 Jun 15. No abstract available.

31.

Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD.

Clin Cancer Res. 2017 Jun 15;23(12):e68-e75. doi: 10.1158/1078-0432.CCR-17-0547. Review.

32.

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D.

Clin Cancer Res. 2017 Jun 1;23(11):e38-e45. doi: 10.1158/1078-0432.CCR-17-0408. Review.

33.

Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.

Walsh MF, Chang VY, Kohlmann WK, Scott HS, Cunniff C, Bourdeaut F, Molenaar JJ, Porter CC, Sandlund JT, Plon SE, Wang LL, Savage SA.

Clin Cancer Res. 2017 Jun 1;23(11):e23-e31. doi: 10.1158/1078-0432.CCR-17-0465. Review.

34.

Pediatric Predispositional Genetic Risk Communication: Potential Utility for Prevention and Control of Melanoma Risk as an Exemplar.

Wu YP, Mays D, Kohlmann W, Tercyak KP.

J Genet Couns. 2017 Oct;26(5):887-893. doi: 10.1007/s10897-017-0105-8. Epub 2017 May 25.

35.

A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management.

Lloyd IE, Kohlmann WK, Gligorich K, Hall A, Lyon E, Downs-Kelly E, Samowitz WS, Bronner MP.

Am J Gastroenterol. 2017 Jul;112(7):1094-1102. doi: 10.1038/ajg.2017.125. Epub 2017 May 2.

PMID:
28462913
36.

Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.

Gupta S, Greenberg S, Grimmett J, Gaston D, Agarwal N, Lowrance W, Schiffman J, Kohlmann W.

Fam Cancer. 2017 Oct;16(4):545-550. doi: 10.1007/s10689-017-9980-2.

PMID:
28315974
37.

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.

Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S.

Breast Cancer Res Treat. 2017 Apr;162(2):225-230. doi: 10.1007/s10549-017-4122-y. Epub 2017 Jan 30. Review.

PMID:
28138892
38.

Reply to P.R. Benusiglio et al.

Kinney AY, Kohlmann W, Brumbach BH, Schwartz MD.

J Clin Oncol. 2017 Apr 10;35(11):1255-1256. doi: 10.1200/JCO.2016.70.9303. Epub 2017 Jan 23. No abstract available.

PMID:
28113008
39.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2017 Jan;15(1):9-20.

PMID:
28040716
40.

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.

Johns D, Agarwal J, Anderson L, Ying J, Kohlmann W.

J Womens Health (Larchmt). 2017 Jun;26(6):702-706. doi: 10.1089/jwh.2016.5931. Epub 2016 Dec 6.

PMID:
27922795
41.

Discussing and managing hematologic germ line variants.

Kohlmann W, Schiffman JD.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):309-315. Review.

42.

Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma.

Wu YP, Aspinwall LG, Nagelhout E, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Cassidy P, Leachman SA.

J Cancer Educ. 2018 Aug;33(4):774-781. doi: 10.1007/s13187-016-1144-9.

43.

Discussing and managing hematologic germ line variants.

Kohlmann W, Schiffman JD.

Blood. 2016 Nov 24;128(21):2497-2503. Review.

PMID:
27881370
44.

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.

Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D.

Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.

PMID:
27501770
45.

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.

Flores KG, Steffen LE, McLouth CJ, Vicuña BE, Gammon A, Kohlmann W, Vigil L, Dayao ZR, Royce ME, Kinney AY.

J Genet Couns. 2017 Jun;26(3):480-490. doi: 10.1007/s10897-016-0001-7. Epub 2016 Aug 6.

46.

Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD.

J Clin Oncol. 2016 Aug 20;34(24):2914-24. doi: 10.1200/JCO.2015.65.9557. Epub 2016 Jun 20.

47.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.

J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.

PMID:
26850485
48.

Multigene testing of moderate-risk genes: be mindful of the missense.

Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, Robinot N, Rosenthal JS, Vallee M, Voegele C, Hopper JL, Southey MC, Andrulis IL, John EM, Hashibe M, Gertz J; Breast Cancer Family Registry, Le Calvez-Kelm F, Lesueur F, Goldgar DE, Tavtigian SV.

J Med Genet. 2016 Jun;53(6):366-76. doi: 10.1136/jmedgenet-2015-103398. Epub 2016 Jan 19.

49.

Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.

Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS, Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS.

J Oncol Pract. 2016 Jan;12(1):59, e1-13. doi: 10.1200/JOP.2015.004838.

50.

Effectiveness of the extended parallel process model in promoting colorectal cancer screening.

Birmingham WC, Hung M, Boonyasiriwat W, Kohlmann W, Walters ST, Burt RW, Stroup AM, Edwards SL, Schwartz MD, Lowery JT, Hill DA, Wiggins CL, Higginbotham JC, Tang P, Hon SD, Franklin JD, Vernon S, Kinney AY.

Psychooncology. 2015 Oct;24(10):1265-1278. doi: 10.1002/pon.3899. Epub 2015 Jul 20.

PMID:
26194469

Supplemental Content

Loading ...
Support Center